Tecentriq misses mark in ovarian cancer trial

14th July 2020 Uncategorised 0

The drug did not extend progression-free survival in patients with newly diagnosed advanced stage ovarian cancer

More: Tecentriq misses mark in ovarian cancer trial
Source: News